BLFSNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

BIOLIFE SOLUTIONS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$38.61+0.00 (0.00%)

Close on Oct 7, 2026

Market cap: $1.90B
P/E (TTM): 33.6
Dividend yield: –

BIOLIFE SOLUTIONS INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Revenue	96	75	68	76	119	48	27	20	11	8.23	6.45	6.19	8.95	5.66	2.76	2.08
Cost of Revenue	34	25	27	–	–	–	8.76	6.22	4.28	3.45	2.63	3.16	5.19	3.37	1.36	1.23
Gross Profit	62	50	41	–	–	–	19	14	6.75	4.78	3.81	3.04	3.76	2.29	1.40	0.86
Research & Development	7.57	4.75	5.52	8.67	12	6.72	3.17	1.30	1.19	2.03	1.38	0.87	0.49	0.46	0.52	0.32
Selling, General & Admin	55	50	54	45	48	22	14	8.57	6.61	7.60	7.45	5.30	3.56	2.77	2.10	1.93
Selling & Marketing	9.85	8.93	11	12	14	6.41	4.70	2.62	2.09	3.01	2.58	1.33	0.84	0.62	0.27	0.43
General & Administrative	46	41	43	33	34	15	8.89	5.95	4.52	4.59	4.87	3.97	2.72	2.15	1.83	1.50
Advertising Expenses	0.40	0.90	0.80	0.40	0.60	0.17	0.04	0.03	0.04	0.07	0.07	0.02	0.00	0.02	0.02	–
Operating Expenses	–	–	–	–	–	–	–	9.86	7.80	9.63	8.83	6.17	4.05	3.23	2.61	2.25
Total Costs & Expenses	79	55	59	82	154	54	28	16	–	–	–	–	–	–	–	–
Operating Income	-17	-4.48	-17	-5.92	-35	-6.24	-0.22	3.66	-1.06	-4.85	-5.02	-3.14	-0.29	-0.94	-1.21	-1.39
Interest Expense	–	–	–	–	–	–	0.01	0.01	0.19	0.10	0	0.18	0.74	0.73	0.67	0.59
Interest & Investment Income	–	–	–	–	–	0.06	0.50	0.28	–	–	–	–	–	–	0.00	0.00
Income from Equity Investments	–	–	–	–	–	0	-0.74	-0.67	-1.01	0	–	–	–	–	–	–
Other Non-Operating Income	4.52	-4.35	4.98	1.08	6.13	4.96	-2.98	-29	-1.46	-3.19	0.02	-0.17	-0.80	-0.72	-0.75	-0.59
Merger & Restructuring Charges	–	–	–	–	–	–	–	–	–	0.10	–	–	–	–	–	–
Asset Impairment Charges	–	–	15	110	0	0	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Investments	0	-4.07	0	0.70	0	1.32	0	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	-0.01	-0.15	-0.63	-0.75	-0.48	0	0	–	0	0.00	0	0.00	0	0.00	0.00	0.00
Pretax Income	-12	-8.82	-12	-4.85	-29	-1.28	-3.20	-25	-2.52	–	–	–	–	–	–	–
Income Tax Expense	0.05	-0.04	-0.06	-5.24	-20	-3.26	-1.54	–	0	0	0	0	0	0	–	–
Income from Continuing Operations	-12	-8.79	-12	0.39	–	–	–	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	7.54	-11	-56	-140	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	-2.52	-8.04	-5.00	-3.30	-1.08	–	–	–
Minority Interest in Earnings	–	–	–	–	–	–	–	–	0	-1.17	-0.78	-0.08	0	–	–	–
Net Income	-4.60	-20	-68	-140	-8.91	1.98	-1.66	-25	-2.52	-6.88	-4.21	-3.22	-1.08	-1.66	-1.96	-1.98
Preferred Dividends	–	–	–	–	–	–	–	0.34	0.21	0	–	–	–	–	–	–
Net Income to Common	–	–	-66	-140	-8.91	1.82	-1.66	-25	-2.73	-6.88	–	–	–	–	–	–
EPS (Basic)(per share)	-0.09	-0.44	-1.55	-3.29	-0.23	0.07	-0.09	-1.56	-0.21	-0.54	-0.35	-0.31	-0.22	-0.33	-0.42	-0.42
EPS (Diluted)(per share)	-0.10	-0.44	-1.55	-3.25	-0.23	-0.06	-0.09	-1.56	-0.21	-0.54	-0.35	-0.31	-0.22	-0.33	-0.42	-0.42
Shares Outstanding (Basic, Weighted)(shares)	48	46	44	42	39	27	19	16	13	13	12	10	5.01	–	–	–
Shares Outstanding (Diluted, Weighted)(shares)	49	46	44	43	39	27	19	16	13	13	12	10	5.01	4.98	4.98	–
EBITDA	-14	0.68	-10	0.85	-30	-4.21	0.50	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 60.4%
Operating margin: 2.9%
Net margin: 56.4%
Return on equity, FY2025: -1.3%

Financial strength

Current ratio: 9.69
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 172.1%

Valuation

P/E ratio: 33.6
Price to sales: 18.51
Price to book: 4.53
Dividend yield: –